Prestige Consumer Healthcare Inc. (PBH): Price and Financial Metrics


Prestige Consumer Healthcare Inc. (PBH): $54.01

0.75 (+1.41%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

PBH POWR Grades


  • PBH scores best on the Growth dimension, with a Growth rank ahead of 92.98% of US stocks.
  • PBH's strongest trending metric is Growth; it's been moving up over the last 179 days.
  • PBH's current lowest rank is in the Momentum metric (where it is better than 8.18% of US stocks).

PBH Stock Summary

  • PBH's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 474.79 -- higher than 94.2% of US-listed equities with positive expected earnings growth.
  • For PBH, its debt to operating expenses ratio is greater than that reported by 83.06% of US equities we're observing.
  • In terms of volatility of its share price, PBH is more volatile than only 12.92% of stocks we're observing.
  • Stocks that are quantitatively similar to PBH, based on their financial statements, market capitalization, and price volatility, are WBT, TNL, WSC, DAN, and PTNR.
  • PBH's SEC filings can be seen here. And to visit Prestige Consumer Healthcare Inc's official web site, go to www.prestigebrands.com.

PBH Valuation Summary

  • In comparison to the median Healthcare stock, PBH's price/sales ratio is 74.45% lower, now standing at 2.9.
  • Over the past 202 months, PBH's price/sales ratio has gone down 9.5.
  • Over the past 202 months, PBH's price/sales ratio has gone down 9.5.

Below are key valuation metrics over time for PBH.

Stock Date P/S P/B P/E EV/EBIT
PBH 2021-08-31 2.9 2 16.1 14.4
PBH 2021-08-30 2.9 2 16.0 14.4
PBH 2021-08-27 2.9 2 15.9 14.3
PBH 2021-08-26 2.9 2 15.7 14.2
PBH 2021-08-25 2.9 2 16.0 14.3
PBH 2021-08-24 2.9 2 16.0 14.4

PBH Growth Metrics

    Its 3 year cash and equivalents growth rate is now at 1.1%.
  • Its 3 year price growth rate is now at -45.07%.
  • Its 4 year net cashflow from operations growth rate is now at 24.53%.
Over the past 15 months, PBH's revenue has gone up $98,034,000.

The table below shows PBH's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 1,057.637 255.883 188.809
2021-09-30 1,021.955 238.813 179.467
2021-06-30 983.152 229.758 178.731
2021-03-31 943.365 235.607 164.682
2020-12-31 956.839 232.646 166.214
2020-09-30 959.603 241.417 163.399

PBH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PBH has a Quality Grade of C, ranking ahead of 40.37% of graded US stocks.
  • PBH's asset turnover comes in at 0.283 -- ranking 157th of 682 Pharmaceutical Products stocks.
  • GHSI, KPTI, and CDTX are the stocks whose asset turnover ratios are most correlated with PBH.

The table below shows PBH's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.283 0.582 0.167
2021-03-31 0.274 0.580 0.159
2020-12-31 0.276 0.579 0.161
2020-09-30 0.277 0.576 0.159
2020-06-30 0.276 0.575 0.152
2020-03-31 0.277 0.573 0.145

PBH Price Target

For more insight on analysts targets of PBH, see our PBH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $63.50 Average Broker Recommendation 1.58 (Moderate Buy)

PBH Stock Price Chart Interactive Chart >

Price chart for PBH

PBH Price/Volume Stats

Current price $54.01 52-week high $63.83
Prev. close $53.26 52-week low $49.09
Day low $52.73 Volume 313,700
Day high $54.13 Avg. volume 276,870
50-day MA $54.50 Dividend yield N/A
200-day MA $57.43 Market Cap 2.71B

Prestige Consumer Healthcare Inc. (PBH) Company Bio


Prestige Brands Holdings markets and distributes brand name over-the-counter health-care and household products throughout the U.S., Canada, Australia, and in certain other international markets. Core brands include Monistat women's health products, Nix lice treatments, Chloraseptic sore throat treatments, Compound W wart treatments, Clear Eyes eye care products, Little Remedies pediatric products, The Doctor's NightGuard dental protector, Efferdent denture care products, Luden's throat drops, Dramamine motion sickness treatments, BC and Goody's headache remedies, Beano gas prevention, Debrox earwax remover, and in Canada, Gaviscon antacid. The company was founded in 1996 and is based in Tarrytown, New York.


PBH Latest News Stream


Event/Time News Detail
Loading, please wait...

PBH Latest Social Stream


Loading social stream, please wait...

View Full PBH Social Stream

Latest PBH News From Around the Web

Below are the latest news stories about Prestige Consumer Healthcare Inc that investors may wish to consider to help them evaluate PBH as an investment opportunity.

With EPS Growth And More, Prestige Consumer Healthcare (NYSE:PBH) Is Interesting

It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...

Yahoo | February 16, 2022

Van Hulzen Asset Management, LLC Buys Vertex Pharmaceuticals Inc, Microsoft Corp, AbbVie Inc, ...

El Dorado Hills, CA, based Investment company Van Hulzen Asset Management, LLC (Current Portfolio) buys Vertex Pharmaceuticals Inc, Microsoft Corp, AbbVie Inc, eBay Inc, Cisco Systems Inc, sells Dollar General Corp, Johnson & Johnson, Tesla Inc, Citigroup Inc, Newmont Corp during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Van Hulzen Asset Management, LLC.

Yahoo | February 4, 2022

What Makes Prestige Brands (PBH) a New Buy Stock

Prestige Brands (PBH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Yahoo | February 4, 2022

Advisor OS, LLC Buys Distillate U.S. Fundamental Stability & Value ETF, BTC BlackRock Short ...

Investment company Advisor OS, LLC (Current Portfolio) buys Distillate U.S. Fundamental Stability & Value ETF, BTC BlackRock Short Maturity Bond ETF, Global X MLP & Energy Infrastructure ETF, Horizon Kinetics Inflation Beneficiaries ETF, VanEck Gold Miners ETF, sells Vanguard FTSE Europe ETF, S&P 500 ETF TRUST ETF, Vanguard Extended Market Index ETF, Vanguard S&P 500 ETF, iShares Cybersecurity and Tech ETF during the 3-months ended 2021Q4, according to the most recent filings of the investment c

Yahoo | February 4, 2022

Prestige Consumer Healthcare GAAP EPS of $0.99 beats by $0.11, revenue of $274.5M beats by $14.11M; raises full year outlook

Prestige Consumer Healthcare press release (NYSE:PBH): FQ3 GAAP EPS of $0.99 beats by $0.11. Revenue of $274.5M (+14.9% Y/Y) beats by $14.11M. The Company's net debt position as of December 31, 2021 was approximately $1.5 billion, resulting in a covenant-defined leverage ratio of 3.9x. Fiscal 2022 outlook: Revenue of $1,075...

Seeking Alpha | February 3, 2022

Read More 'PBH' Stories Here

PBH Price Returns

1-mo 1.45%
3-mo N/A
6-mo -7.90%
1-year 9.35%
3-year 83.90%
5-year 9.41%
YTD -10.95%
2021 73.93%
2020 -13.90%
2019 31.15%
2018 -29.59%
2017 -14.76%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9863 seconds.